Inflammatory Ly-6Chi monocytes play an important role in the development of severe transplant arteriosclerosis in hyperlipidemic recipients

Atherosclerosis

Volumn 223, Issue 2, 2012, Pages 291-298

  Schiopu, Alexandru ^a   Nadig, Satish N ^a   Cotoi, Ovidiu S ^b   Hester, Joanna ^a   Van Rooijen, Nico ^c   Wood, Kathryn J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Hypercholesterolemia; Inflammation; Macrophages; Monocytes; Transplant vasculopathy

Indexed keywords

APOLIPOPROTEIN E; CD11B ANTIGEN; LYSINE; MICROSPHERE;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOSCLEROSIS; ARTICLE; CELL POPULATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; GRAFT RECIPIENT; HEART GRAFT; HYPERLIPIDEMIA; IN VIVO STUDY; INFLAMMATION; LONG TERM SURVIVAL; MACROPHAGE; MALE; MONOCYTE; MOUSE; NEOINTIMA; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VASCULAR DISEASE; WILD TYPE;

ANIMALS; ANTIGENS, CD11B; ANTIGENS, LY; AORTA; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; CHOLESTEROL; DISEASE MODELS, ANIMAL; FEMALE; HYPERLIPIDEMIAS; INFLAMMATION; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, KNOCKOUT; MONOCYTES; NEOINTIMA; NEUTROPHILS; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES; UP-REGULATION;

EID: 84864766748     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.05.010     Document Type: Article

References (30)

1. Hunt S.A., Haddad F. The changing face of heart transplantation. J Am Coll Cardiol 2008, 52:587-598.
2. Schmauss D., Weis M. Cardiac allograft vasculopathy: recent developments. Circulation 2008, 117:2131-2141.
3. Rahmani M., Cruz R.P., Granville D.J., McManus B.M. Allograft vasculopathy versus atherosclerosis. Circ Res 2006, 99:801-815.
4. Hillebrands J.L., Rozing J. Chronic transplant dysfunction and transplant arteriosclerosis: new insights into underlying mechanisms. Expert Rev Mol Med 2003, 5:1-23.
5. Taylor D.O., Edwards L.B., Boucek M.M., et al. Registry of the international society for heart and lung transplantation: twenty-fourth official adult heart transplant report-2007. J Heart Lung Transplant 2007, 26:769-781.
6. Valantine H. Cardiac allograft vasculopathy after heart transplantation: risk factors and management. J Heart Lung Transplant 2004, 23:S187-S193.
7. Tuzcu E.M., Kapadia S.R., Sachar R., et al. Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation. J Am Coll Cardiol 2005, 45:1538-1542.
8. Winters G.L., Kendall T.J., Radio S.J., et al. Posttransplant obesity and hyperlipidemia: major predictors of severity of coronary arteriopathy in failed human heart allografts. J Heart Transplant 1990, 9:364-371.
9. Eich D., Thompson J.A., Ko D.J., et al. Hypercholesterolemia in long-term survivors of heart transplantation: an early marker of accelerated coronary artery disease. J Heart Lung Transplant 1991, 10:45-49.
10. Kobashigawa J.A., Kasiske B.L. Hyperlipidemia in solid organ transplantation. Transplantation 1997, 63:331-338.
11. Kobashigawa J.A., Starling R.C., Mehra M.R., et al. Multicenter retrospective analysis of cardiovascular risk factors affecting long-term outcome of de novo cardiac transplant recipients. J Heart Lung Transplant 2006, 25:1063-1069.
12. McManus B.M., Horley K.J., Wilson J.E., et al. Prominence of coronary arterial wall lipids in human heart allografts. Implications for pathogenesis of allograft arteriopathy. Am J Pathol 1995, 147:293-308.
13. Russell P.S., Chase C.M., Colvin R.B. Accelerated atheromatous lesions in mouse hearts transplanted to apolipoprotein-E-deficient recipients. Am J Pathol 1996, 149:91-99.
14. Shi C., Lee W.S., Russell M.E., et al. Hypercholesterolemia exacerbates transplant arteriosclerosis via increased neointimal smooth muscle cell accumulation: studies in apolipoprotein E knockout mice. Circulation 1997, 96:2722-2728.
15. Tanaka H., Sukhova G.K., Libby P. Interaction of the allogeneic state and hypercholesterolemia in arterial lesion formation in experimental cardiac allografts. Arterioscler Thromb 1994, 14:734-745.
16. Ensminger S.M., Billing J.S., Morris P.J., Wood K.J. Development of a combined cardiac and aortic transplant model to investigate the development of transplant arteriosclerosis in the mouse. J Heart Lung Transplant 2000, 19:1039-1046.
17. Schiopu A., Bengtsson J., Soderberg I., et al. Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis. Circulation 2004, 110:2047-2052.
18. Tacke F., Alvarez D., Kaplan T.J., et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 2007, 117:185-194.
19. Geissmann F., Jung S., Littman D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003, 19:71-82.
20. Daley J.M., Thomay A.A., Connolly M.D., Reichner J.S., Albina J.E. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J Leukoc Biol 2008, 83:64-70.
21. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695.
22. Galle J., Hansen-Hagge T., Wanner C., Seibold S. Impact of oxidized low density lipoprotein on vascular cells. Atherosclerosis 2006, 185:219-226.
23. Cherepanova O.A., Pidkovka N.A., Sarmento O.F., et al. Oxidized phospholipids induce type VIII collagen expression and vascular smooth muscle cell migration. Circ Res 2009, 104:609-618.
24. Kitchens W.H., Chase C.M., Uehara S., et al. Macrophage depletion suppresses cardiac allograft vasculopathy in mice. Am J Transplant 2007, 7:2675-2682.
25. Swirski F.K., Libby P., Aikawa E., et al. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Investig 2007, 117:195-205.
26. Swirski F.K., Wildgruber M., Ueno T., et al. Myeloperoxidase-rich Ly-6C+ myeloid cells infiltrate allografts and contribute to an imaging signature of organ rejection in mice. J Clin Investig 2010, 120:2627-2634.
27. Murphy A.J., Akhtari M., Tolani S., et al. ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice. J Clin Investig 2011, 121:4138-4149.
28. Wenke K., Meiser B., Thiery J., et al. Simvastatin initiated early after heart transplantation: 8-year prospective experience. Circulation 2003, 107:93-97.
29. Pakala R., Stabile E., Jang G.J., Clavijo L., Waksman R. Rapamycin attenuates atherosclerotic plaque progression in apolipoprotein E knockout mice: inhibitory effect on monocyte chemotaxis. J Cardiovasc Pharmacol 2005, 46:481-486.
30. Keogh A., Richardson M., Ruygrok P., et al. Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial. Circulation 2004, 110:2694-2700.